Studies using the IKK inhibitor PS-1145 have confirmed the role of NF-kB in the growth, survival, and drug resistance of MM cells and therefore raised interest in the targeting of NF-kB in MM (121). This evidence concerns the gene NFKB1 and Miyoshi myopathy.